CHINA IP LAW HUB
Equip yourself with the latest trends and analysis of China’s intellectual property laws
Embracing risk
As capital markets resurrect, how can businesses capitalise on opportunities amid risks and nagging uncertainties?
Multinational antitrust reviews in pharma M&A
In recent years, M&A in the global biopharmaceutical sector has remained highly active
Walking a fine line
With uncertainty now the norm, how should general counsel navigate between risk and growth?
Out-licensing is in
China's out-licensing boom: legal experts share tips for seamless pharma deals
Walking the sanctions tightrope
How can multinationals adapt as China strengthens its anti-foreign sanction defences?
IP protection and corporate response to malicious litigation
Malicious IP litigation is disrupting fair competition in China, prompting corporations and regulators
Challenges of technical investigation officers in civil litigation
Challenges faced by technical investigation officers in civil litigation and their evolving role
On the agenda: China’s IP ecosystem
China will dominate Asia sessions at INTA, with its new president highlighting key IP issues on the agenda
Watch our INTA interview!
INTA’s APAC factor
INTA's chief in Asia-Pacific discusses the big issues and notable developments for IP in the region
Don’t settle, be nimble
We spoke with Jomarie Fredericks, the 2023 INTA president, about upcoming events, her goals, and how to balance with her GC responsibilities
NEWS
